Shionogi Stock
StockStockPrice
Historical dividends and forecast
Shionogi has so far distributed $0.177 in 2024. The next dividend will be paid on 02.12.2024
CHART BY
Frequently asked questions
What is Shionogi's market capitalization?
What is Shionogi's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Shionogi?
What are the analyst ratings and target price for Shionogi's stock?
What is Shionogi's revenue over the trailing twelve months?
Is Shionogi paying dividends?
What is the EBITDA for Shionogi?
What is the free cash flow of Shionogi?
What is the 5-year beta of Shionogi's stock?
How many employees does Shionogi have, and what sector and industry does it belong to?
What is the free float of Shionogi's shares?
Financials
Market Cap
$12.08B5Y beta
0.76EPS (TTM)
$1.158Free Float
807.46MP/E ratio (TTM)
11.72Revenue (TTM)
$2.68BEBITDA (TTM)
$966.69MFree Cashflow (TTM)
$558.68MPricing
Analyst Ratings
The price target is $16.78 and the stock is covered by 13 analysts.
Buy
8
Hold
4
Sell
1
Information
Shionogi & Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses. The prescription drug business is engaged in the development of eight new drugs including hypercholesterolemia treatment drugs Crestor, antihypertensive drugs Ilbetan Family (Irbetan, Aimix, Iltra) and antidepressant drugs Sinbalta. The Company is engaged in the provision of information to contribute to medical care by maximizing its products. The over-the-counter (OTC) pharmaceutical business handles products tailored to customers' lifestyles. The in-vitro diagnostics business is engaged in the sale of products, as well as the provision of information on infectious diseases, cardiovascular diseases and allergic diseases. The Company mainly provides its products and services in Japan, Europe and North America markets.
4,959
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker